Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21880569 | 0.93 | ESR2 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL121800 | 0.91 | CA4 (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13940030 | 0.91 | ACHE (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16698731 | 0.91 | CA4 (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4157842 | 0.91 | ACHE (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL26862 | 0.91 | CA4 (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13939384 | 0.89 | APP (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL21551879 | 0.89 | CA4 (0.52) | CA1CA2CA7CA9CA12 | |
| Ammonia Solution, Strong SCHEMBL17187816 | 0.89 | CA4 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13096614 | 0.89 | NFE2L2 (0.53) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504882-A | Synthesis method of GalNAc derivative | 北京炫景瑞医药科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119019354-A | Compound and preparation method and application thereof | 北京炫景瑞医药科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-4217508-A1 | APPARATUS, KITS AND METHODS FOR PREDICTING THE DEVELOPMENT OF SEPSIS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2023-08-02 | — | — | EP | claimed |
| WO-2022064163-A1 | APPARATUS, KITS AND METHODS FOR PREDICTING THE DEVELOPMENT OF SEPSIS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2022-03-31 | — | — | WO | claimed |
| CN-114249786-A | Preparation and application of nucleoside intermediate containing N, N-diacyl structure | 上海彩迩文生化科技有限公司 | 2022-03-29 | — | — | CN | claimed |
| US-4800166-A | TRITYL HALIDE OR CARVOXYLATE TO BIND WITH FREE AMINO GROUPS | APPLIED PROTEIN TECHNOLOGIES, INC. (US) | 1989-01-24 | — | — | US | claimed |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | AM CHEMICALS LLC (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2025111589-A1 | COMPOSITIONS AND METHODS FOR ENHANCING DRUG RESISTANCE IN CELLS | MEDICI THERAPEUTICS, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2024240101-A9 | GALNAC COMPOUND, CONJUGATE, COMPOSITION, AND USE THEREOF | 北京炫景瑞医药科技有限公司 | 2025-03-06 | — | — | WO | disclosed |
| CN-119504882-A | Synthesis method of GalNAc derivative | 北京炫景瑞医药科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-20250042931-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2025-02-06 | — | — | US | disclosed |
| WO-2024240101-A1 | GALNAC COMPOUND, CONJUGATE, COMPOSITION, AND USE THEREOF | 北京炫景瑞医药科技有限公司 | 2024-11-28 | — | — | WO | disclosed |
| CN-119019354-A | Compound and preparation method and application thereof | 北京炫景瑞医药科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-4800166-A | TRITYL HALIDE OR CARVOXYLATE TO BIND WITH FREE AMINO GROUPS | APPLIED PROTEIN TECHNOLOGIES, INC. (US) | 1989-01-24 | — | — | US | disclosed |
| EP-0135587-A4 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0135587-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS. | MOLECULAR BIOSYSTEMS INC (US) | 1985-04-03 | — | — | EP | disclosed |
| WO-1984003285-A1 | DEFINED SEQUENCE SINGLE STRAND OLIGONUCLEOTIDES INCORPORATING REPORTER GROUPS, PROCESS FOR THE CHEMICAL SYNTHESIS THEREOF, AND NUCLEOSIDES USEFUL IN SUCH SYNTHESIS | MOLECULAR BIOSYSTEMS INC (US) | 1984-08-30 | — | — | WO | disclosed |
| US-4203898-A | ANTICARCINOGENIC | ELI LILLY AND COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4082736-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4082735-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042931-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | MPO, MUC1, CRYAB | CA1 609/4885CA2 1218/4885CA7 519/4885 |
| US-20260125413-A1 | UNIVERSAL SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE SYNTHESIS | SSU72, NSUN2, POLR2H | CA1 1306/4885CA2 1718/4885CA7 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.